KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Edwards Lifesciences (EW) Shares Repurchased (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of Shares Repurchased data on record, last reported at $40.6 million in Q4 2025.

  • For Q4 2025, Shares Repurchased fell 59.44% year-over-year to $40.6 million; the TTM value through Dec 2025 reached $893.4 million, down 22.94%, while the annual FY2025 figure was $893.4 million, 22.94% down from the prior year.
  • Shares Repurchased reached $40.6 million in Q4 2025 per EW's latest filing, down from $588.7 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $901.0 million in Q3 2024 and bottomed at $200000.0 in Q1 2024.
  • Average Shares Repurchased over 5 years is $258.6 million, with a median of $166.2 million recorded in 2023.
  • Peak YoY movement for Shares Repurchased: crashed 99.92% in 2024, then soared 129200.0% in 2025.
  • A 5-year view of Shares Repurchased shows it stood at $96.5 million in 2021, then soared by 797.41% to $866.0 million in 2022, then crashed by 48.22% to $448.4 million in 2023, then plummeted by 77.68% to $100.1 million in 2024, then plummeted by 59.44% to $40.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Repurchased were $40.6 million in Q4 2025, $588.7 million in Q3 2025, and $5.5 million in Q2 2025.